{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions ad"],"components":["Active, inactive ad"],"effective_time":"20190522","id":"897e88a9-c011-22f1-e053-2a95a90afdb2","instructions_for_use":["Directions for use s"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 1022-2 BENZOYL PEROXIDE USP 2.5% / CLINDAMYCIN PHOSPHATE USP 1% / NIACINAMIDE USP 2% / TRETINOIN USP 0.025%. Gel 30 gm sf"],"set_id":"897e88a9-c010-22f1-e053-2a95a90afdb2","spl_product_data_elements":["BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025% BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 2% / TRETINOIN 0.025% TRETINOIN TRETINOIN BENZOYL PEROXIDE BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE CLINDAMYCIN NIACINAMIDE NIACINAMIDE"],"version":"1"}